- $565.55m
- $444.47m
- $209.92m
- 71
- 28
- 32
- 40
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 177 | 223 | 270 | 242 | 210 |
Cost of Revenue | |||||
Gross Profit | 52.3 | 59.4 | 77.3 | 50.8 | 46.1 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 187 | 244 | 300 | 297 | 257 |
Operating Profit | -9.91 | -21 | -30.2 | -55.1 | -46.8 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -6.76 | -20.6 | -30 | -54.2 | -42.6 |
Provision for Income Taxes | |||||
Net Income After Taxes | -12.9 | -20.9 | -29.7 | -54.6 | -41.7 |
Net Income Before Extraordinary Items | |||||
Net Income | -12.9 | -20.9 | -29.7 | -54.6 | -41.7 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -12.9 | -20.9 | -29.7 | -54.6 | -41.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.338 | -0.546 | -0.704 | -1.17 | -0.893 |